U.S. Markets closed

  • S&P 500

    4,109.31
    +58.48 (+1.44%)
     

  • Dow 30

    33,274.15
    +415.12 (+1.26%)
     

  • Nasdaq

    12,221.91
    +208.43 (+1.74%)
     

  • Russell 2000

    1,802.48
    +34.10 (+1.93%)
     

  • Crude Oil

    75.70
    +1.33 (+1.79%)
     

  • Gold

    1,987.00
    -10.70 (-0.54%)
     

  • Silver

    24.24
    +0.25 (+1.03%)
     

  • EUR/USD

    1.0847
    -0.0062 (-0.5640%)
     

  • 10-Yr Bond

    3.4940
    -0.0570 (-1.61%)
     

  • Vix

    18.70
    -0.32 (-1.68%)
     

  • GBP/USD

    1.2332
    -0.0058 (-0.4686%)
     

  • USD/JPY

    132.7970
    +0.1080 (+0.0814%)
     

  • BTC-USD

    28,349.84
    +2.94 (+0.01%)
     

  • CMC Crypto 200

    621.79
    +7.58 (+1.23%)
     

  • FTSE 100

    7,631.74
    +11.31 (+0.15%)
     

  • Nikkei 225

    28,041.48
    +258.55 (+0.93%)
     

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX): Is Breakeven Near?

Simply Wall St
·3 min read

We feel now is a pretty good time to analyse BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) business as it appears the company may be on the cusp of a considerable accomplishment. BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The US$1.9b market-cap company posted a loss in its most recent financial year of US$184m and a latest trailing-twelve-month loss of US$193m leading to an even wider gap between loss and breakeven. As path to profitability is the topic on BioCryst Pharmaceuticals' investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

Check out our latest analysis for BioCryst Pharmaceuticals

BioCryst Pharmaceuticals is bordering on breakeven, according to the 8 American Biotechs analysts. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$45m in 2025. Therefore, the company is expected to breakeven roughly 2 years from today. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 62% is expected, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected.

earnings-per-share-growth
earnings-per-share-growth

Underlying developments driving BioCryst Pharmaceuticals' growth isn’t the focus of this broad overview, though, take into account that generally biotechs, depending on the stage of product development, have irregular periods of cash flow. This means that a high growth rate is not unusual, especially if the company is currently in an investment period.

Before we wrap up, there’s one issue worth mentioning. BioCryst Pharmaceuticals currently has negative equity on its balance sheet. This can sometimes arise from accounting methods used to deal with accumulated losses from prior years, which are viewed as liabilities carried forward until it cancels out in the future. These losses tend to occur only on paper, however, in other cases it can be forewarning.

Next Steps:

There are too many aspects of BioCryst Pharmaceuticals to cover in one brief article, but the key fundamentals for the company can all be found in one place – BioCryst Pharmaceuticals' company page on Simply Wall St. We've also compiled a list of relevant factors you should look at:

  1. Valuation: What is BioCryst Pharmaceuticals worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether BioCryst Pharmaceuticals is currently mispriced by the market.

  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on BioCryst Pharmaceuticals’s board and the CEO’s background.

  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

Recommended Stories

  • Seeking at Least 8% Dividend Yield? Goldman Sachs Suggests 2 Dividend Stocks to Buy

    One thing is certain in the stock markets lately: their inherent uncertainty is taking charge, and high volatility is here to stay. For months, investors and economists have worried about the recessionary effects of the Federal Reserve’s anti-inflationary interest rate hikes – but the recent bank crisis has added another layer of concern to an already tumultuous situation. Now, we’re dealing with the fallout from that crisis, and inflation and interest rates both remain high. It’s a textbook cas

  • Schwab Hit by Worst Month Since 1987 Amid Cash Sorting Woes

    (Bloomberg) -- Charles Schwab Corp.’s worst month in more than 35 years has sparked a debate among analysts as to whether the brokerage giant has been unfairly punished by investors amid growing fears about the US banking sector.Most Read from BloombergParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leave RussiaVeteran Money Managers Bail on Stock Rally With Fed Hawks FlyingTrump Faces Fingerprints, Mug Shot After Dramatic I

  • US Power Plant Firm Goes Bankrupt After Winter Storm Penalties

    (Bloomberg) -- Lincoln Power LLC, the owner of two Illinois power plants, filed for bankruptcy after its financial strain was exacerbated by nearly $39 million in penalties levied by the biggest US electric-grid operator. Most Read from BloombergParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leave RussiaVeteran Money Managers Bail on Stock Rally With Fed Hawks FlyingTrump Faces Fingerprints, Mug Shot After Dramatic Indictme

  • A $200,000 Annuity Will Pay Out This Much a Month

    An annuity can be an appealing option to build your retirement nest egg. Adding guaranteed retirement income to your retirement can give you financial stability. But the exact amount that you'll get from an annuity each month will vary. Let's … Continue reading → The post How Much Does a $200,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

  • Procrastinators, Rejoice: The 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years

    With a yield of 9.62%, the recently expired Series I bond was understandably popular. With interest rates rising, bond funds are down this year and banks continue to offer miserly rates on deposit accounts. So it's no wonder that a … Continue reading → The post It Pays to Procrastinate: The New 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years appeared first on SmartAsset Blog.

  • El-Erian: Warning Signs Are Now Flashing Yellow

    Mohamed El-Erian, chief economic adviser at Allianz and Bloomberg Opinion columnist, says the worst of the recent turmoil in banking is over, but there are still warning signs. "We're going from liquidity to capital, and from financial contagion to economic contagion," El-Erian said in an interview on Bloomberg Television in Cernobbio, Italy. El-Erian's opinions are his own. Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com Connect with us on... Twitter: https://twitter.com/business Facebook: https://www.facebook.com/bloombergbusiness/ Instagram: https://www.instagram.com/quicktake/?hl=en

  • Altria Lays Out a Transition to Smokeless Products. But It Begins With the Dividend.

    The biggest cigarette company in the U.S. acknowledges that it has to move toward smokeless products. But to hold its shareholder base, it also knows it has to grow an already rich dividend.

  • Baby Boomers, You Need This Much Money to Retire Comfortably

    The Baby Boomer generation is reaching retirement age in record numbers. With more Boomers retiring on a daily basis, it helps to understand how prepared they are to leave their jobs for good. In this article, we’ll discuss the average … Continue reading → The post Average Retirement Savings for Baby Boomers appeared first on SmartAsset Blog.

  • 7 Dividend Stocks for Uncertain Economic Times

    Treasuries aren't the only refuge in a slowdown. Dividend names also "can provide a margin of safety," says UBS.

  • The Charles Schwab Corporation (SCHW) Stock Sinks As Market Gains: What You Should Know

    The Charles Schwab Corporation (SCHW) closed the most recent trading day at $52.38, moving -0.17% from the previous trading session.

  • Three Stocks Turn $10,000 To $25,265 In Just 3 Months

    Investors enjoyed a small S&P 500 rally in March. But there were much more lucrative places to put money in the month.

  • Soaring Auto Loan Rates Are the Latest Roadblock for Car Sales

    (Bloomberg) -- Just when it seemed like things were getting back to normal at Rhett Ricart’s Columbus, Ohio, car dealerships — after pandemic-induced inventory shortages and runaway price inflation — a new obstacle emerged to keep buyers from closing the deal: soaring interest rates on auto loans.Most Read from BloombergParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leave RussiaVeteran Money Managers Bail on Stock Rally Wit

  • Republic First Is ‘NOT’ First Republic, But Try Telling Traders That

    (Bloomberg) -- A case of mistaken identity is sparking a selloff in Republic First Bancorp Inc., which had fallen by more than 40% this month because investors have it confused with embattled First Republic Bank.Most Read from BloombergParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsGlobal Food Supply Risks Rise as Key Traders Leave RussiaVeteran Money Managers Bail on Stock Rally With Fed Hawks FlyingTrump Faces Fingerprints, Mug Shot After Dramatic IndictmentSchwab H

  • How to make $100,000 or more and pay no income taxes

    Here’s how to earn a six-figure income and pay no income taxes on it – totally legally.

  • Virgin Orbit’s sudden collapse is the latest in a series of high-risk failures by Richard Branson

    The satellite deployment startup founded by Branson is letting go of the bulk of its staff, citing an “inability to secure meaningful funding.”

  • Japan's Toyota hands St Petersburg plant over to Russian state

    MOSCOW (Reuters) -Russia and Toyota said on Friday that the Japanese carmaker's factory in St Petersburg had been handed over to state entity NAMI, with Moscow snapping up more assets from global automakers leaving Russia over the conflict in Ukraine. "Toyota's production site in St Petersburg has... been transferred to the state," Russia's Ministry of Industry and Trade said in a statement. The company said in September it had decided to stop vehicle production in Russia due to the interruption in supplies of key materials and parts.

  • Dow Jones Rises 150 Points After Cool Inflation Data; 6 Stocks To Buy And Watch

    The Dow Jones rose Friday after key inflation data, with the release of the PCE price index, the Fed's preferred measure of inflation.

  • The Newest ‘Bubble’ Is in Money-Market Funds

    People are rushing into money-market funds. Total assets held in money-market funds, which are investment vehicles that buy cash-like securities such as short-term Treasury bills, recently reached close to $5.5 trillion, according to RBC. Earlier this year, money-market fund assets stood at roughly $4.5 trillion, a level at which people stopped pouring more money into those funds a few times in the past few years, opting instead to buy other assets like stocks.

  • Market Rally Builds Momentum; Tesla Breaks Out With Deliveries Due

    The market rally is building momentum with more stocks flashing buy signals. Tesla deliveries are due as EV rivals report Q1 sales.

  • Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks?

    Regardless of what stage of the market cycle we're in, some folks never tire of searching for cheap stocks to buy. If it has thin trading volume, the fund manager will have an awfully tough time accumulating shares — without making a big impact on the stock price. IBD research also finds that dozens, if not hundreds, of great stocks each year do not start out as penny shares.